AKT1 and neoplasm: However, livers in the mice group injected with myr-AKT plus NRAS plasmids with shSetd3 displayed a rather normal morphology and smaller liver sizes and showed compromised tumor development, although liver sizes were still 1.1-fold larger than the control group, but 3-fold smaller than the shCtrl group (Figures 5B–D).